Omega Healthcare Investors’ Index Exit Puts Fresh Focus on the Stock

Omega Healthcare Investors (OHI) was removed from the Russell 1000 Dynamic Index on 27 June 2026, an index change that can influence institutional trading patterns and short term share price moves.

This shift puts a spotlight on how Omega Healthcare Investors, a healthcare focused REIT with a market cap of about US$15.0b, fits into portfolios that target income, real assets, or healthcare exposure.

At a share price of US$47.68, Omega Healthcare Investors has seen its 90 day share price return of 7.56% and one year total shareholder return of 38.38% draw fresh attention. The recent index removal is likely contributing to short term trading swings as investors reassess income and healthcare REIT exposure.

If this index change has you thinking more broadly about where to put fresh capital to work, it can be useful to scan for other resilient real asset and income opportunities alongside Omega Healthcare Investors using the 20 top founder-led companies

With Omega Healthcare Investors delivering a 38.38% one year total shareholder return and trading at US$47.68, the key question now is simple: is the stock still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 6.2% Undervalued

Compared with the last close at $47.68, the most followed narrative tags Omega Healthcare Investors with a fair value of $50.82, setting up a modest undervaluation story based on discounted future earnings and cash flows.

Omega's disciplined balance sheet management and opportunistic use of both debt and equity (with a low leverage ratio at decade lows and largely fixed-rate debt) position the company to pursue high-yield acquisitions and portfolio expansion at accretive rates, supporting long-term AFFO and net earnings growth.

Curious what underpins that fair value gap? The narrative leans on steady revenue, higher profit margins, and a richer future earnings multiple to justify the price tag.

Result: Fair Value of $50.82 (UNDERVALUED)

However, the Omega Healthcare Investors story still hinges on tenant credit and reimbursement risk. Issues like the Genesis bankruptcy or potential Medicare and Medicaid changes could pressure rental income.

Another View On Omega Healthcare Investors’ Valuation

The DCF style fair value narrative suggests Omega Healthcare Investors is modestly undervalued, but the P/E story looks different. At 23.1x earnings, OHI trades above the Global Health Care REITs average of 20x and below a fair ratio of 32.5x. This raises a simple question: is the stock cheap, or just less expensive than it could be?

See what the numbers say about this price in our valuation breakdown, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Seeing both optimism and concern around Omega Healthcare Investors in this article, it makes sense to check the underlying data yourself and move quickly to form your own view. A useful place to start is the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Omega Healthcare Investors?

If Omega Healthcare Investors has sharpened your focus on income and quality, do not stop here. Broaden your opportunity set before the next move passes you by.

• Explore potential high income by scanning for steady payers and strong yields through the 10 dividend fortresses.
• Extend your research by searching for potential mispriced quality using the screener containing 19 high quality undiscovered gems.
• Increase resilience in your portfolio by focusing on sturdier financial profiles with the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.